Francois Binette - 22 Jul 2022 Form 3 Insider Report for Enochian Biosciences Inc (RENB)

Role
Executive Vice President
Signature
/s/ Francois Binette
Issuer symbol
RENB
Transactions as of
22 Jul 2022
Net transactions value
$0
Form type
3
Filing time
18 Aug 2022, 12:41:03 UTC
Next filing
27 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RENB Option to purchase shares of Common Stock 22 Jul 2022 Common Stock 65,000 $2.38 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was issued in connection with the Company's employee retention plan.
F2 60% of the option will vest on January 22, 2023; the balance will vest on July 22, 2023.